IDEAYA Biosciences (NASDAQ:IDYA) PT Raised to $60.00 at Citigroup

IDEAYA Biosciences (NASDAQ:IDYA – Free Report) had its target price upped by Citigroup from $40.00 to $60.00 in a report published on Thursday morning, Benzinga reports. They currently have a buy rating on the stock. A number of other brokerages have also recently issued reports on IDYA. Leerink Partnrs reiterated an outperform rating on shares […]

Related Keywords

United States ,Hong Kong ,China ,Leerink Partnrs ,Briseno Andres Ruiz ,Werner Helicase ,Yujiros Hata ,Biosciences Inc ,Life Insurance Co ,China Universal Asset Management Co ,Hong Kong Ltd ,Goldman Sachs Group ,Jpmorgan Chase Co ,Biosciences Company Profile ,Citigroup ,Free Report ,One Financial ,Trading Down ,Get Free Report ,Kong Ltd ,Universal Asset Management ,Pol Theta Helicase ,Ideaya Biosciences ,Nasdaq Idya ,Nidya ,Medical ,Boost Price Target ,Citigroup Inc ,